[{"address1": "2450 Holcombe Blvd", "address2": "MS: BCM251", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 45, "title": "Co-Founder, CEO, President, Treasurer, Secretary & Director", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 400000, "exercisedValue": 0, "unexercisedValue": 9390}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria-Bernadette  Madel Ph.D.", "age": 35, "title": "Director of Corporate Operations & External Communications", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Newman Ph.D.", "age": 66, "title": "Head of Regulatory Affairs", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr., Ph.D.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.04, "open": 2.0, "dayLow": 1.9807, "dayHigh": 2.13, "regularMarketPreviousClose": 2.04, "regularMarketOpen": 2.0, "regularMarketDayLow": 1.9807, "regularMarketDayHigh": 2.13, "payoutRatio": 0.0, "beta": 1.372, "forwardPE": -2.6582277, "volume": 221082, "regularMarketVolume": 221082, "averageVolume": 362755, "averageVolume10days": 586430, "averageDailyVolume10Day": 586430, "bid": 2.06, "ask": 2.15, "bidSize": 1, "askSize": 1, "marketCap": 35013564, "fiftyTwoWeekLow": 0.81, "fiftyTwoWeekHigh": 4.07, "allTimeHigh": 6120000.0, "allTimeLow": 0.67, "priceToSalesTrailing12Months": 7.4576473, "fiftyDayAverage": 1.4498, "twoHundredDayAverage": 1.27215, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 17423588, "profitMargins": 0.0, "floatShares": 13676466, "sharesOutstanding": 16673127, "sharesShort": 326551, "sharesShortPriorMonth": 233661, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0196, "heldPercentInsiders": 0.05493, "heldPercentInstitutions": 0.20703, "shortRatio": 1.15, "shortPercentOfFloat": 0.0475, "impliedSharesOutstanding": 16673127, "bookValue": 1.103, "priceToBook": 1.9038982, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -14298034, "trailingEps": -1.17, "forwardEps": -0.79, "lastSplitFactor": "1:10", "lastSplitDate": 1674777600, "enterpriseToRevenue": 3.711, "52WeekChange": 0.08808291, "SandP52WeekChange": 0.15024745, "quoteType": "EQUITY", "currentPrice": 2.1, "targetHighPrice": 10.0, "targetLowPrice": 5.6, "targetMeanPrice": 7.86667, "targetMedianPrice": 8.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 17589978, "totalCashPerShare": 1.055, "totalDebt": 0, "quickRatio": 5.755, "currentRatio": 6.496, "totalRevenue": 4694988, "revenuePerShare": 0.368, "returnOnAssets": -0.55195, "returnOnEquity": -1.10672, "grossProfits": -9066857, "freeCashflow": -10881111, "operatingCashflow": -14817110, "revenueGrowth": -0.36, "grossMargins": -1.93118, "ebitdaMargins": 0.0, "operatingMargins": -1.73304, "financialCurrency": "USD", "symbol": "MRKR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 2.94117, "regularMarketPrice": 2.1, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1026826200000, "postMarketChangePercent": -1.4285702, "postMarketPrice": 2.07, "postMarketChange": -0.029999971, "regularMarketChange": 0.0599999, "regularMarketDayRange": "1.9807 - 2.13", "exchange": "NCM", "messageBoardId": "finmb_1725474", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Marker Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1769213521, "regularMarketTime": 1769202001, "priceEpsCurrentYear": -2.245989, "fiftyDayAverageChange": 0.6501999, "fiftyDayAverageChangePercent": 0.44847557, "twoHundredDayAverageChange": 0.82784986, "twoHundredDayAverageChangePercent": 0.6507486, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "longName": "Marker Therapeutics, Inc.", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 362755, "fiftyTwoWeekLowChange": 1.29, "fiftyTwoWeekLowChangePercent": 1.5925926, "fiftyTwoWeekRange": "0.81 - 4.07", "fiftyTwoWeekHighChange": -1.9700003, "fiftyTwoWeekHighChangePercent": -0.48402953, "fiftyTwoWeekChangePercent": 8.8082905, "dividendDate": 1473984000, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.17, "epsForward": -0.79, "epsCurrentYear": -0.935, "displayName": "Marker Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-24"}]